Literature DB >> 30424681

Immunization with plasmids encoding M2 acetylcholine muscarinic receptor epitopes impairs cardiac function in mice and induces autophagy in the myocardium.

Karla Consort Ribeiro1,2, Roberto Perez Campelo1,3, Daniela Del Rosário Flores Rodrigues1,3, Elisabete C Mattos4, Izaira Trincani Brandão5, Célio Lopes da Silva5, Eliete Bouskela6, Camila Guerra Martinez1,7, Eleonora Kurtenbach1,7.   

Abstract

Autoantibodies against the M2 subtype of muscarinic acetylcholine receptors with functional activities have been found in the sera of patients with dilated cardiomyopathy (DCM), and the second extracellular loop has been established as the predominant epitope. However, it has been shown that the third intracellular loop is recognized by Chagas disease patients with severe cardiac dysfunction. In this work, BALB/c mice were immunized with plasmids encoding these two epitopes, and a control group received the empty plasmid (pcDNA3 vector). Serum from these DNA-immunized animals had elevated and persistent titres of antibodies against respective antigens. Heart echocardiography indicated diminished left ventricular wall thickness and reduced ejection fraction for both epitope-immunized groups, and ergospirometry tests showed a significant decrease in the exercise time and oxygen consumption. Transfer of serum from these immunized mice into naïve recipients induced the same alterations in cardiac structure and function. Furthermore, electron microscopy analysis of donor-immunized animals revealed several ultrastructural alterations suggestive of autophagy and mitophagy, suggesting novel roles for these autoantibodies. Overall, greater functional and structural impairment was observed in the donor and recipient epitope groups, implicating the third intracellular loop epitope in the pathological effects for the first-time. Therefore, the corresponding peptides could be useful for autoimmune DCM diagnosis and targeted therapy.

Entities:  

Keywords:  DNA immunization; autoimmunity; autophagy; dilated cardiomyopathy; muscarinic M2 acetylcholine receptor

Mesh:

Substances:

Year:  2018        PMID: 30424681     DOI: 10.1080/08916934.2018.1514389

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  4 in total

Review 1.  Autoantibodies as Endogenous Modulators of GPCR Signaling.

Authors:  Meredith A Skiba; Andrew C Kruse
Journal:  Trends Pharmacol Sci       Date:  2020-12-24       Impact factor: 14.819

2.  Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE-/- mice.

Authors:  Zhu Wang; Jingjing Guo; Xinqiang Han; Ming Xue; Wenming Wang; Lei Mi; Yuguo Sheng; Chao Ma; Jian Wu; Xuejun Wu
Journal:  Cell Biosci       Date:  2019-08-27       Impact factor: 7.133

3.  Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatment.

Authors:  Guiling Ma; Long Chen; Yin Yue; Xiyan Liu; Yidan Wang; Cheng Shi; Fei Song; Wei Shi; Yingshih Lo; Lin Zhang
Journal:  BMC Cardiovasc Disord       Date:  2021-12-28       Impact factor: 2.298

4.  Viral gene delivery vectors: the next generation medicines for immune-related diseases.

Authors:  Peter De Haan; Ferdy R Van Diemen; Miguel G Toscano
Journal:  Hum Vaccin Immunother       Date:  2020-05-15       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.